Nϵ-Carboxymethyl-Lysine Deteriorates Vascular Calcification in Diabetic Atherosclerosis Induced by Vascular Smooth Muscle Cell-Derived Foam Cells

• Príomhchruthaitheoirí: Sui-Ning Xu (Údar), Xin Zhou (Údar), Cun-Jun Zhu (Údar), Wei Qin (Údar), Jie Zhu (Údar), Ke-Lin Zhang (Údar), Hui-Jin Li (Údar), Lu Xing (Údar), Kun Lian (Údar), Cheng-Xiang Li (Údar), Zhen Sun (Údar), Zhong-Qun Wang (Údar), An-Ji Zhang (Údar), Hui-Ling Cao (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Nϵ-carboxymethyl-lysine (CML), an advanced glycation end product, is involved in vascular calcification (VC) in diabetic atherosclerosis. This study aimed to investigate the effects of CML on VC in diabetic atherosclerosis induced by vascular smooth muscle cell (VSMC)-derived foam cells. Human studi...